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INTRODUCTION
The etiology of attention deficit hyperactivity disorder 
(ADHD) is not completely understood, but it is well known 
that the genetic transmission is an important factor in 
ADHD etiology.1 In particular, it is supposed to be a complex 
psychiatric disorder which also involves the interaction of 
gene and environment.2 Despite the studies reporting associ-
ation between ADHD and serotonergic system, genes of do-
paminergic system are the mostly blamed system genes 
among the genetic factors.3,4 However, recently, researchers 
suppose that the problem at the synaptic gap is not only lim-
ited to the dopamine, but also there may be problems in the 
modulation of neurotransmitter releasing and synaptogene-
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sis, and they targetted their efforts towards the genes encod-
ing presynaptic proteins having roles in those processes.5
Vesicle-associated membrane protein 2 (VAMP2) (synap-
tobrevin 2) and syntaxin 1A along with The synaptosomal-
associated protein, 25 kDa (SNAP-25) protein compose 
SNARE proteins that have roles in the modulation of neu-
rotransmitter releasing.6 Among these genes, the most fre-
quently studied one is SNAP-25 gene and the relation be-
tween ADHD and two polymorphisms of (MnlI, DdeI) this 
gene was investigated in many studies. A relation between ei-
ther or both DdeI and MnlI polymorphisms are found to be 
related with ADHD.7-9 A relation between ADHD and 
SNAP-25 MnlI polymorphism was determined in a study 
which was performed in our country, Turkey.10 In another 
study from Turkey, the changes in the brain bloodstream 
with single dose of psychostimulant in ADHD subjects were 
analyzed and they reported that brain bloodstream may be 
affected by SNAP-25 polymorphism after psychostimulant 
therapy.11 All these studies have brought up the other pro-
teins that have roles in the same function along with SNAP-
25. However, no study was noticed investigating the relation 
between VAMP2 and syntaxin 1A genes and ADHD in the 
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literature. Yet, there are some studies investigating the rela-
tion between VAMP2 and syntaxin 1A genes and various 
psychiatric disorders that the modulation of neurotransmit-
ter releasing is important in their etiopathogenesis.
No relation was obtained between the gene polymor-
phisms of SNARE proteins; VAMP2, syntaxin 1A and SNAP-
25 and schizophrenia.12 No relation was obtained between 
VAMP2 gene and bipolar disease, which has a comorbid di-
agnosis rate of 9.5% with ADHD, in a study that was per-
formed among bipolar patients.13,14
While no relation was determined between schizophrenia 
and exon 3 polymorphism of syntaxin 1A gene, a relation 
was reported between schizophrenia and intron 7 T>C poly-
morphism of syntaxin 1A gene.15 In the post-mortem brain 
studies of the schizophrenia patients, higher levels of syntax-
in 1A in cingulat cortices and higher levels of syntaxin 1A m-
RNA in temporal cortices with respect to the control subjects 
were determined.16,17 Bartl et al.18 reported that they observed 
reduction in the syntaxin 1A m-RNA levels and down-regu-
lation in synaptic proteins after administration of methyl-
phenidate (MPH) in a study which they have investigated 
the effects of MPH, currently used in the treatment of 
ADHD.
In this study, we aimed to investigate the relation between 
VAMP-2 and syntaxin 1A genes, which have roles in encod-
ing presynaptic proteins, and ADHD.
METHODS
Subjects
A total of 139 patients between ages of 18 and 60, meeting 
DSM-IV criteria for adult ADHD were included into the 
study. The control group consisted of 106 healthy subjects 
between ages of 18 and 60. All participants were recruited 
from the research center and were of Turkish origin. A writ-
ten consent to participate in the study was obtained from the 
subjects after they were thoroughly informed about the re-
search details. Approval of the study was given by the ethics 
committee of the Pamukkale University. Comorbid psychiat-
ric disorders in ADHD and the control group were evaluated 
with Structured Clinical Interview For DSM-IV Axis I Dis-
orders (SCID I) ve Structured Clinical Interview For DSM-
IIIR Personality Disorders (SCID II). Exclusion criteria were 
psychotic disorder, severe neurological comorbidity, epilepsy, 
mental retardation and unliterate in ADHD and control 
groups. Patients were evaluated with Wender Utah Rating 
Scale (WURS) and Adult Attention Deficit Hyperactivity 
Disorder Diagnosis and Evaluation Scale. Patients, who 
scored 36 points or more on the WURS and answered at 
least 6 of 9 questions as 2 or 3 of first and second parts of 
Adult Attention Deficit Hyperactivity Disorder Diagnosis 
and Evaluation Scale were diagnosed as ADHD. The control 
group was also evaluated with WURS and Adult Attention 
Deficit Hyperactivity Disorder Diagnosis and Evaluation 
Scale and subjects who met adult ADHD criteria were ex-
cluded from the control group.
Instruments
Social demographic data form
A data sheet developed by the researchers for studying so-
cio-demographic characteristics of study groups.
Wender-Utah Rating Scale (WURS)
This scale can be used to assess adults for Attention Deficit 
Hyperactivity Disorder with a subset of 25 questions associ-
ated with that diagnosis. WURS was developed by Ward and 
Wender in 1993.19 Turkish validity and reliability of WURS 
was established by Oncü et al.20 and the cut-off score point 
was 36.
Adult ADD/ADHD DSM IV-Based Diagnostic 
Screening and Rating Scale
Adult Attention Deficit Hyperactivity Disorder Diagnosis 
and Evaluation Scale were developed by Turgay in 1995. It is 
a self assessment scale and patients can complete the ques-
tionnaire after being duly informed. When developing adult 
ADD/ADHD Scale, 18 symptoms of the diagnostic criteria 
in DSM-IV were reframed, so patients can understand them. 
Turkish validity and reliability was established by Gunay and 
colleagues.21
Structured Clinical Interview For DSM-IV Axis I 
Disorders (SCID I)
It is a semi-structured interview for making the major 
DSM-IV Axis I diagnoses.22
Structured Clinical Interview For DSM-IIIR Personality 
Disorders (SCID II)
It is a semi-structured interview for making DSM-IV Axis 
II: Personality Disorder diagnoses.23
DNA Isolation and Molecular Analysis
For the amplification of VAMP 2 gene 26 bp Ins/Del poly-
morphism, DNA was isolated from peripheral blood leuko-
cytes by standard phenol/chloroform method and genotyped 
by polymerase chain reaction (PCR) method. PCR was per-
formed with a personal thermal cycler (Techgene, NJ, USA), 
using VAMP2 F-5’-ACAAAGTGCGCCTTATACGC-3’/ 
VAMP2 R-5’-GATTTTCCTTGACGACACTC-3’ primers.
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For the amplification of Syntaxin 1A gene intron 7 poly-
morphism (rs35459363), DNA was isolated from peripheral 
blood leukocytes by standard phenol/chloroform method 
and genotyped by polymerase chain reaction-restriction 
fragment length polymorphism (PCR-RFLP) method. PCR 
was performed with a personal thermal cycler (Techgene, NJ, 
USA), using STAX2 F-5’-CAATGCTGCTGCTGAACTC-3’/ 
STAX2 R-5’-CGCTGACATTTATGTGACC-3’ primers.
Statistical analysis
Statistical Package for the Social Sciences (SPSS) version 
10.0 for Windows computing program was used for statisti-
cal analysis of the data. Chi-square test was used to compare 
categorical variables and independent samples t test was used 
to compare continuous variables. Logistic regression analysis 
was used to assess the risk. A p value of <0.05 was accepted 
statistically significant.
RESULTS
A total of 139 patients with adult ADHD and 106 healthy 
controls were included into the study. Mean age of the study 
group was 27.12±9.77 and mean age of the control group 
was 27.86±7.88. There was no significant difference between 
study and control groups regarding age (p>0.05). The study 
group consisted of 61 women (43.9%) and 78 men (56.1%) 
and the control group consisted of 41 women (38.7%) and 65 
men (61.3%). There was also no significant difference be-
tween study and control groups regarding gender (p>0.05). 
Frequencies of comorbid psychiatric disorder diagnoses and 
results of WURS and adult ADHD rating scale scores in 
ADHD and the control groups were shown in Table 1 and 2.
Of the 139 patients with adult ADHD, 40 (28.8%) were di-
agnosed as predominantly inattentive type, 39 (28.1%) were 
diagnosed as predominantly hyperactive-impulsive type and 
60 (43.2%) were diagnosed as combined type of ADHD.
VAMP 2 gene results of the groups
Because of technical problems, genomic DNAs for the 
VAMP 2 gene could not be obtained from 5 of the 139 pa-
tients and 7 of the 106 control subjects, and they were not in-
cluded into the genotype distribution and allele frequency 
results for this gene.
When frequencies of VAMP 2 Ins/Del polymorphism 
genotypes were compared according to gender, no statistical-
ly significant difference was found between the genders in 
Table 1. Frequencies of comorbid psychiatric disorder diagnoses
 ADHD Control  Total
SCID I
No comorbidity 48 (32.9%) 98 (67.1%) 146 (100.0%)
Depressive disorders 39 (97.5%) 1 (2.5%) 40 (100.0%)
Panic disorders 1 (100.0%) 0 (0%) 1 (100.0%)
OCD 6 (85.7%) 1 (14.3%) 7 (100.0%)
GAD 23 (100.0%) 0 (0%) 23 (100.0%)
Bipolar disorders 9 (90.0%) 1 (10.0%) 10 (100.0%)
Somatoform disorders 2 (100.0%) 0 (0%) 2 (100.0%)
Social phobia 3 (75.0%) 1 (25.0%) 4 (100.0%)
Adjustment disorders 8 (66.7%) 4 (33.3%) 12 (100.0%)
Total 139 (56.7%) 106 (43.3%) 245 (100.0%)
SCID II
No comorbidity 92 (49.2%) 95 (50.8%) 187 (100.0%)
OCPD 7 (70.0%) 3 (30.0%) 10 (100.0%)
Avoidant PD 2 (33.3%) 4 (66.7%) 6 (100.0%)
Borderline PD 16 (94.1%) 1 (5.9%) 17 (100.0%)
Narcissistic PD 3 (100.0%) 0 (0%) 3 (100.0%)
Histrionic PD 4 (80.0%) 1 (20.0%) 5 (100.0%)
Self defeating PD 5 (71.4%) 2 (28.6%) 7 (100.0%)
Antisocial PD 10 (100.0%) 0 (0%) 10 (100.0%)
Total 139 (56.7%) 106 (43.3%) 245 (100.0%)
ADHD: attention deficit hyperactivity disorder, SCID: Structured Clinical Interview for DSM-IV, OCD: obsessive compulsive disorder, GAD: 
generalized anxiety disorder, OCPD: obsessive compulsive personality dosirder, PD: panic disorder
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both ADHD and the control group (p>0.05) (Table 3).
When the groups were compared according to VAMP 2 
gene 26 bp Ins/Del polymorphism allele frequencies; in 
ADHD group, Ins allele (patient: 83.2%, control: 70.2%) and 
in the control group, Del allele (patient: 16.8%, control: 
29.8%) was determined more often and the difference be-
tween the groups was found statistically significant 
(p=0.001). When the groups were compared according to 
genotype frequencies; in ADHD group, 69.4% of them had 
Ins/Ins genotype, 27.6% of them had Ins/Del genotype, 3.0% 
of them had Del/Del genotype and in the control group, 
42.4% of them had Ins/Ins genotype, 55.6% of them had Ins/
Del genotype and 2.0% of them had Del/Del genotype. The 
difference between the groups was found statistically signifi-
cant (p<0.001).
Ins allele was determined in 97.0% of ADHD group and in 
98.0% of the control group and there was no significant dif-
ference between the groups (p>0.05). When the groups were 
compared with respect to the Del allele, ADHD group and 
the control group were found to have statistically significant-
ly different (p<0.001) rates of Del allele which were 30.6% 
and 57.6% respectively (Table 4).
When Ins/Ins and Ins/Del genotypes of VAMP 2 gene Ins/
Del polymorphism were compared, the rate of Ins/Ins geno-
type was higher (71.5%) in ADHD group and the rate of Ins/
Del genotype was higher (56.7%) in the control group 
(p<0.001). When Ins/Ins and Del/Del genotypes and Ins/Del 
and Del/Del genotypes were compared with each other, no 
significant difference was determined (p>0.05).
In the logistic regression analysis, when Ins/Del genotype 
was regarded as reference, the possibility of having Ins/Ins 
genotype in the subjects diagnosed as ADHD is 3 times 
Table 2. Results of WURS and Adult ADD/ADHD Scale scores
Scale Mean* SD
WURS 
ADHD 47.14 14.27
Control 19.31 11.21
Inattention symptoms 
ADHD 5.65 2.32
Control 1.04 1.61
Inattention points 
ADHD 15.49 5.37
Control 6.55 3.84
Hyperactivity/impulsivity symptoms 
ADHD 6.10 2.03
Control 1.49 1.67
Hyperactivity/impulsivity points
ADHD 16.82 4.98
Control 6.33 4.52
*t-test was performed. WURS: Wender-Utah Rating Scale, Adult 
ADD/ADHD Scale: Adult Attention Deficit Hyperactivity Disor-
der Diagnosis and Evaluation Scale, ADHD: attention deficit hy-
peractivity disorder
Table 3. Frequencies of VAMP 2 Ins/Del polymorphism genotypes according to genders
 VAMP 2 gene
 Total p value*
Ins/Ins Ins/Del Del/Del
ADHD 0.324
Female 38 (64.4%) 18 (30.5%) 3 (5.1%) 59 (100.0%)
Male 55 (73.3%) 19 (25.3%) 1 (1.3%) 75 (100.0%)
Total 93 (69.4%) 37 (27.6%) 4 (3.0%) 134 (100.0%)
Control 0.442
Female 18 (50.0%) 17 (47.2%) 1 (2.8%) 36 (100.0%)
Male 24 (38.1%) 38 (60.3%) 1 (1.6%) 63 (100.0%)
Total 42 (42.4%) 55 (55.6%) 2 (2.0%) 99 (100.0%)
*chi-square test was performed. VAMP 2: vesicle-associated membrane protein 2, ADHD: attention deficit hyperactivity disorder 
Table 4. Frequencies of VAMP 2 gene Ins/Del polymorphism
ADHD, n (%) Control, n (%) p value*
Allele frequencies 0.001**
Ins 223 (83.2) 139 (70.2)
Del 45 (16.8) 59 (29.8)
Total 268 (100.0) 198 (100.0)
Genotype frequencies 0.000**
Ins/Ins 93 (69.4) 42 (42.4)
Ins/Del 37 (27.6) 55 (55.6)
Del/Del 4 (3.0) 2 (2.0)
Total 134 (100.0) 99 (100.0)
Presence or absence of Ins and Del alleles
Ins/Ins+Insl/Del 130 (97.0) 97 (98.0) 1.000
Del/Del+Ins/Del 41 (30.6) 57 (57.6) 0.000**
*chi-square test was performed, **p<0.05. VAMP 2: vesicle-associ-
ated membrane protein 2, ADHD: attention deficit hyperactivity 
disorder
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higher than the subjects that are not ADHD (p<0.001, 95% 
CI: 1.637-5.362). When Ins/Ins genotype was regarded as 
reference, the possibility of having Ins/Del genotype in the 
subjects that are not ADHD is 40% higher than the subjects 
diagnosed as ADHD (p<0.001, 95% CI: 0.186-0.611). The 
possibility of having Ins allele in the subjects diagnosed as 
ADHD is 2 times higher than the subjects that are not 
ADHD (p=0.011, 95% CI: 1.166-3.283).
When ADHD subtypes and genotype distributions were 
compared, Ins/Ins genotype was found the most often in the 
predominantly inattentive type (74.4%) and Ins/Del geno-
type was found the most often in the combined type (31.0%). 
The difference between the subtypes was not found statisti-
cally significant (p>0.05).
Syntaxin 1A gene intron 7 polymorphism results 
of the groups
Because of technical problems, genomic DNAs for the 
Syntaxin 1A gene could not be obtained from 5 of the 139 
patients and 8 of the 106 control subjects, and they were not 
included into the genotype distribution and allele frequency 
results for this gene.
In ADHD group, when frequencies of Syntaxin 1A gene 
intron 7 polymorphism genotypes were compared according 
to gender; genotype frequency among females was as fol-
lows: 8.5% T/T genotype, 69.5% T/C genotype, 22.0% C/C 
genotype, and among males was as follows: 20.0% T/T geno-
type, 46.7% T/C genotype, 33.3% C/C genotype. The differ-
ence between the genders was found statistically significant 
(p=0.024). In the control group, no statistically significant 
difference was found between the genders (p>0.05) (Table 5).
When the groups were compared according to Syntaxin 
1A gene intron 7 polymorphism allele frequencies; in ADHD 
group, T allele (patient: 43.3%, control: 24.5%) and in the 
control group, C allele (patient: 56.7%, control: 75.5%) was 
determined more often and the difference between the 
groups was found statistically significant (p<0.001). When 
the groups were compared according to genotype frequen-
cies; in ADHD group, 14.9% of them had T/T genotype, 
56.7% of them had T/C genotype, 28.4% of them had C/C 
genotype and in the control group, 6.1% of them had T/T 
genotype, 36.7% of them had T/C genotype and 57.1% of 
them had C/C genotype. The difference between the groups 
was found statistically significant (p<0.001).
T allele was determined in 71.6% of the ADHD group and 
in 42.9% of the control group, and C allele was determined 
in 85.1% of the ADHD group and in 93.9% of the control 
group and the difference between the groups was found sta-
tistically significant (respectively p<0.001, p=0.036) (Table 6).
When T/T and C/C genotypes of Syntaxin 1A gene intron 
7 polymorphism were compared with each other, T/T geno-
type was found statistically significantly higher (34.5%) in 
ADHD group and C/C genotype was found significantly 
higher (90.3%) in the control group (p<0.001). Yet, when T/
Table 5. Frequencies of STX 1A intron 7 polymorphism genotypes according to genders
STX 1A Gene
Total p value
T/T T/C C/C
ADHD 0.024**
Female 5 (8.5%) 41 (69.5%) 13 (22.0%) 59 (100.0%)
Male 15 (20.0%) 35 (46.7%) 25 (33.3%) 75 (100.0%)
Total 20 (14.9%) 76 (56.7%) 38 (28.4%) 134 (100.0%)
Control 0.197
Female 1 (2.8%) 17 (47.2%) 18 (50.0%) 36 (100.0%)
Male 5 (8.1%) 19 (30.6%) 38 (61.3%) 62 (100.0%)
Total 6 (6.1%) 36 (36.7%) 56 (57.1%) 98 (100.0%)
*chi-square test was performed, **p<0.05. STX: syntaxin 1A, ADHD: attention deficit hyperactivity disorder
Table 6. Frequencies of Syntaxin 1A gene intron 7 polymorphism
ADHD, n (%) Control, n (%) p value*
Allele frequencies 0.000**
T 116 (43.3) 48 (24.5)
C 152 (56.7) 148 (75.5)
Total 268 (100.0) 196 (100.0)
Genotype frequencies 0.000**
T/T 20 (14.9) 6 (6.1)
T/C 76 (56.7) 36 (36.7)
C/C 38 (28.4) 56 (57.1)
Total 134 (100.0) 98 (100.0)
Presence or absence of T and C alleles
T/T+T/C 96 (71.6) 42 (42.9) 0.000**
C/C+T/C 114 (85.1) 92 (93.9) 0.036**
*chi-square test was performed, **p<0.05. ADHD: attention defi-
cit hyperactivity disorder
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C and C/C genotypes were compared with each other, T/C 
genotype was found statistically significantly higher (66.7%) 
in ADHD group and C/C genotype was found statistically 
significantly higher (60.9%) in the control group (p<0.001). 
When T/T and T/C genotypes were compared with each 
other, no significant difference was determined (p>0.05).
In the logistic regression analysis, when T/T+T/C geno-
type was regarded as reference, the possibility of having C/C 
genotype in the subjects that are not ADHD is 30% higher 
than the subjects diagnosed as ADHD (p<0.001, 95% CI: 
0.178-0.584). The possibility of having T allele in the subjects 
diagnosed as ADHD is 2.6 times higher than the subjects 
that are not ADHD (p<0.001, 95% CI: 1.667–4.001).
When ADHD subtypes and genotype distribution were 
compared, T/T and T/C genotypes were found the most of-
ten in the predominantly inattentive type (respectively 17.9% 
and 64.1%) and C/C genotype was found the most often in 
the combined type (36.2%). There was no significant differ-
ence between the subtypes of ADHD (p=0.406).
DISCUSSION
The relation between ADHD and SNAP-25 gene, which 
have a role in the modulation of neurotransmitter releasing 
together with VAMP2 and syntaxin 1A, was investigated in 
many studies. A relation between ADHD and (ATTT)n poly-
morphism in the microsatellite region of SNAP-25 gene was 
determined.24 The studies investigating the relation between 
ADHD and MnlI and DdeI polymorphisms of SNAP-25 
gene have reported different results. Brophy et al. have re-
ported no significant relation between ADHD and MnlI 
polymorphism, but they have also reported significant rela-
tion between ADHD and DdeI polymorphism.7 Another 
study has reported significant relation between ADHD and 
MnlI and DdeI polymorphisms of SNAP-25 gene.8 In a meta-
analysis study, a relation between ADHD and MnlI polymor-
phism of SNAP-25 gene was reported.9 Recently, a relation 
between ADHD and SNAP-25 gene is mentioned in the 
pharmacogenetic studies. In a study performed in spontane-
ously hypertansive rats, Li et al.25 reported that the decreased 
synthesis of SNAP-25 m-RNA in the prefrontal cortex have 
recruited after repetitive amphetamine injections. Öner et 
al.11 have reported that hemodynamic changes in the brain 
induced by methylphenidate might be related with SNAP-25 
gene polymorphisms in a Functional Near-Infrared Spec-
troscopy (fNIRS) study performed with 15 ADHD adults 
and 16 ADHD children.
VAMP-2 gene has been studied in many psychiatric disor-
ders except ADHD. In a study which the relation of schizo-
phrenia and SNARE proteins are investigated, no relation 
was reported between schizophrenia and polymorphisms of 
syntaxin1A, SNAP-25 and VAMP2 genes.12 In a study per-
formed among Japan people, the relation of VAMP2 gene 
rs8067606, rs1061032 and rs 2278637 polymorphisms and 
the antidepressant response of major depressive patients was 
investigated and no distinct relation was reported.26 In a 
study performed among patients of bipolar disorder that has 
a co-morbidity frequency of 9.5% with ADHD, any distinct 
relation was not reported between bipolar disorder and 
VAMP2 gene rs2278637 ve rs8067606 polymorphisms.13,14 In 
a candidate thesis study in Turkey, the relation between the 
polymorphisms of the genes encoding presynaptic proteins 
and Alzheimer disease was investigated.27 In terms of 
VAMP2 gene Ins/Del polymorphism, allele distribution was 
found as follows: 87.5% Ins allele and 12.5% Del allele in Al-
zheimer patients and 79.5% Ins allele and 20.5% Del allele in 
the control group. Also in the same study, Ins/Del genotype 
was reported to have 0.3 times protective effect for Alzheim-
er disease. In the present study, allele distributions were simi-
lar to the aforementioned study and the possibility of having 
Ins/Del genotype in the subjects that are not ADHD is 40% 
higher than the subjects diagnosed as ADHD. When it is 
considered that both of the studies are performed among the 
same ethnic people, it is noteworthy that the similar allele 
distribution rates of Ins/Del genotype show protective effect 
for both ADHD and Alzheimer disease. It can also be sup-
posed that this genotype is associated with the symptoms 
rather than the disorder when it is considered that there are 
problems in learning, attention and memory in both disor-
ders. In another point of view, it can be suggested that 
VAMP-2 polymorphism (Ins/Del genotype) can be active on 
the attention and can be a useful marker to explain the atten-
tion deficiency in ADHD and Alzheimer disease. 
Moreover, in the present study, in the subjects diagnosed 
as ADHD, the possibility of having Ins/Ins genotype is 3 
times higher and the possibility of having Ins allele is 2 times 
higher than the subjects that are not ADHD.
Bartl et al.18 studied the association of ADHD and MPH, 
which is used in the treatment of it, and have observed re-
duction of Syntaxin 1A m-RNA levels and down-regulation 
at the synaptic proteins following the administration of MPH 
and have suggested that these findings show a strong associa-
tion with extracellular dopamine levels. Binda et al.28 studied 
the association of dopamine and Syntaxin 1A, and reported 
that while amphetamine did not result in the transport of 
dopamine out of the cell at the physiologic resting potential 
(-60 mV) in human DAT cells and dopaminergic neurons, 
the administration of exogenous Syntaxin 1A to the intracel-
lular compartment resulted in the transport of dopamine out 
of the cell. In another study performed to investigate the as-
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sociation of Syntaxin 1A and schizophrenia, where dopa-
mine plays an important role in its physiopathology as 
ADHD, no association was determined between the disorder 
and exon 3 polymorphism. But, a significant correlation was 
determined between schizophrenia and intron 7 T>C poly-
morphism, and C allele was found higher in schizophrenic 
patients compared to the controls.15 In the present study, a 
significant correlation between Syntaxin 1A gene intron 7 
polymorphism and ADHD was determined. Also, the possi-
bility of having T allele in the subjects diagnosed as ADHD 
is 2,6 times higher than the subjects that are not ADHD. 
Nonetheless, the possibility of having C/C genotype in the 
subjects that are not ADHD is 30% higher than the subjects 
diagnosed as ADHD.
As a result, it is supposed that genes encoding presynaptic 
proteins that have roles in the modulation of neurotransmit-
ter releasing and synaptogenesis play roles in the genetic eti-
ology of ADHD as some of the psychiatric disorders. But 
considering both the previous studies together with the pres-
ent study, that which genes are active in which conditions 
and how much, and what kind of an interaction there is be-
tween these genes is still not so clear. To the best of our 
knowledge, the present study is the first one which investi-
gates the association between ADHD and VAMP 2 gene Ins/
Del polymorphism and Syntaxin 1A gene Intron 7 polymor-
phism in the English literature, and it seems that there may 
be an association between ADHD and these genes.
Limitations of the study are that the number of the patient 
and the control groups are not much enough, impossibility 
of excluding familial genetic load completely, the genes inter-
act with each other besides their relation with the disorder.
As a conclusion, it is supposed that genes encoding synap-
tic proteins that were analyzed in the present study may also 
be important in the genetic etiology of ADHD. The present 
study is supposed to form a base for the forthcoming gene 
research.
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